We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Fat Development Leads to Pancreatic Cell Transplant Failure

By Biotechdaily staff writers
Posted on 10 Sep 2007
Researchers have found that the failure of pancreatic cell transplants to provide a lasting source of insulin is due in part to the toxic effect of high levels of fats that form in the vicinity of the transplant.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) were seeking factors other than immune rejection that could explain the poor results obtained by pancreatic cell transplant therapy. More...


The investigators transplanted beta cells into the livers of rats that had been chemically treated to mimic human insulin-dependent, or juvenile diabetes (type 1), a condition in which pancreatic beta cells are unable to produce insulin. Some of the animals were also treated to reduce production of fats, either by restricting diet or by receiving leptin, a hormone that decreases appetite and increases metabolism.

Results published in the September 2007 issue of the journal Diabetes revealed that after an initial increase in insulin production the untreated rats developed fat accumulations within four weeks after transplantation. Insulin levels declined, and the animals died at 15 weeks. In the two treated groups, more beta cells survived with rats that had received leptin, showing the highest survival rate of beta cells.

"By understanding how fat affects these cells, maybe we can improve islet transplant and make it last a bit longer,” said senior author Dr. Roger Unger, professor of internal medicine at the University of Texas Southwestern Medical Center. "This seems very easy to prevent, but it's not being targeted by researchers.”


Related Links:
University of Texas Southwestern Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.